---------- Forwarded message ----------
From: PlusNews <[email protected]>
Date: Wed, Dec 7, 2011 at 12:53 PM
Subject: HIV/AIDS: Depression "overlooked" in treating HIV patients
To: Elisabeth Janaina <[email protected]>


HIV/AIDS: Depression "overlooked" in treating HIV patients

ADDIS ABABA, 7 December 2011 (PLUSNEWS) - HIV patients in Africa
frequently suffer shame and depression but the continent's health
systems are ill-equipped to handle the issue, which not only affects
their quality of life, but can lead to poor adherence to HIV treatment
regimens.

 While HIV programmes focus heavily on reducing externalized stigma
and ill-treatment of HIV patients by society, little is done to deal
with a patients' self-perception and how that might deteriorate
following an HIV diagnosis, speakers said at a session on stigma at
the 16th International Conference on AIDS and Sexually transmitted
infections in Africa in Addis Ababa.

 Studies show that depression is the most common psychiatric disorder
among people living with HIV, and is more prevalent among HIV-positive
people than the general population.

 "Operational research carried out in Zambia has found a positive
correlation between patients who self-stigmatized and failure to
adhere to treatment," said Sikazwe Izukanyi from Zambia's Ministry of
Health. "Self-stigma was often found in patients who did not disclose
their status to partners or family members - making it difficult to
maintain strict adherence to regimens while trying to hide the drugs."

 Izukanyi noted that while counselling was a standard part of HIV care
in Zambia, counsellors needed to be made aware of the prevalence of
self-stigma and how to deal with it.

 A 2010 Ugandan study [
http://www.ajol.info/index.php/ajpsy/article/viewFile/53429/42000 ] by
Makerere University found that HIV-positive patients were more
critical of themselves, had significantly greater problems making
decisions, poorer sleep, tired more easily, experienced more appetite
changes and had more cognitive impairment.

 ARVs and self-stigma

 According to a study by Yordanos Tiruneh, an Ethiopian academic with
US-based Northwestern University, antiretroviral (ARV) therapy has
been key to reducing external stigma by minimizing the visibility of
physical imperfections and restoring functional daily activities such
as the ability to work. The study, which used 105 interviews with
Ethiopian men and women on ARVs, also found that the support networks
formed by people living with HIV gave them much-needed social capital.

 However, according to Yordanos, while ARVs were linked to a reduction
in external stigma, the study found that they tended to increase
internalized stigma, sometimes resulting in failure to properly adhere
to ARVs.

 "When I think of the two tablets that keep me alive, I hate myself
and I feel that I am dead," one of the study's interviewees is quoted
as saying. "Sometimes I get furious to see myself like a walking
corpse, and other times I see myself as a doll that functions with a
battery. I would say, without these batteries [pills], I am nothing."

 According to a US study [ http://www.ncbi.nlm.nih.gov/pubmed/15764960
], adherence to ARVs was higher in patients for whom anti-depressants
were prescribed.

 A severe shortage of mental health professionals in Africa means that
HIV-associated depression is largely ignored. For instance, according
to the UN World Health Organization [
http://www.who.int/entity/bulletin/volumes/89/3/BLT-10-082784-table-T3.html
], Burundi has just one psychosocial care provider per 100,000,
against a target of at least eight, while Ethiopia has less than one,
against a similar target.

 "The problem is largely a human resources one; while strengthening
health systems, governments should remember to focus on mental-health
issues," said Izukanyi. "As it is, we have no systems for screening,
diagnosing and treating patients with mental-health issues."

 Among other things, experts recommend [
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948731 ] integrating
mental-health services into primary healthcare activities, developing
mechanisms to ensure a good supply of psychotropic medication and more
research into mental-health issues in Africa.

 kr/mw

[END]

This report online: http://www.plusnews.org/report.aspx?reportID=94410



Follow us on Twitter! http://twitter.com/plusnews

© IRIN. All rights reserved. HIV/AIDS news and analysis:
http://www.plusnews.org/

[This item comes to you from PlusNews, part of IRIN, the humanitarian
news and analysis service of the UN Office for the Coordination of
Humanitarian Affairs. The opinions expressed do not necessarily
reflect those of the United Nations or its Member States. Reposting or
reproduction, with attribution, for non-commercial purposes is
permitted. Terms and conditions:
http://www.irinnews.org/copyright.aspx

Principal IRIN/PlusNews donors: UAE, Canada, Germany, Ireland,
Netherlands, Norway, Sweden, Switzerland, UK and the IHC. More
information: http://www.irinnews.org/donors.aspx

This mail is from an automatic address. Contact PlusNews at:
[email protected]. Revise/stop your subscription:
http://bit.ly/9nCoUP ]

Subscribed email: [email protected]

-- 
You received this message because you are subscribed to the Google Groups 
"South Sudan Info - The Kob" group.
To post to this group, send email to [email protected].
To unsubscribe from this group, send email to 
[email protected].
For more options, visit this group at 
http://groups.google.com/group/SouthSudanKob?hl=en.

Reply via email to